These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33679480)

  • 1. COVID-19 Social Restrictions: An Opportunity to Re-visit the Concept of Harm Reduction in the Treatment of Alcohol Dependence. A Position Paper.
    Kouimtsidis C; Pauly B; Parkes T; Stockwell T; Baldacchino AM
    Front Psychiatry; 2021; 12():623649. PubMed ID: 33679480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "There is a Place": impacts of managed alcohol programs for people experiencing severe alcohol dependence and homelessness.
    Pauly B; Brown M; Evans J; Gray E; Schiff R; Ivsins A; Krysowaty B; Vallance K; Stockwell T
    Harm Reduct J; 2019 Dec; 16(1):70. PubMed ID: 31842903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review.
    Krawczyk N; Fawole A; Yang J; Tofighi B
    Addict Sci Clin Pract; 2021 Nov; 16(1):68. PubMed ID: 34774106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "We have to be uncomfortable and creative": Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia.
    Aronowitz SV; Engel-Rebitzer E; Lowenstein M; Meisel Z; Anderson E; South E
    SSM Qual Res Health; 2021 Dec; 1():100013. PubMed ID: 34870265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
    Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
    Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse.
    Muckle W; Muckle J; Welch V; Tugwell P
    Cochrane Database Syst Rev; 2012 Dec; 12():CD006747. PubMed ID: 23235633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the outside looking in: Finding a place for managed alcohol programs in the harm reduction movement.
    Ivsins A; Pauly B; Brown M; Evans J; Gray E; Schiff R; Krysowaty B; Vallance K; Stockwell T
    Int J Drug Policy; 2019 May; 67():58-62. PubMed ID: 30959410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managed alcohol: one community's innovative response to risk management during COVID-19.
    Brocious H; Trawver K; Demientieff LX
    Harm Reduct J; 2021 Dec; 18(1):125. PubMed ID: 34872581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Potential of Implementing Managed Alcohol Programmes to Reduce Risk of COVID-19 Infection and Transmission, and Wider Harms, for People Experiencing Alcohol Dependency and Homelessness in Scotland.
    Parkes T; Carver H; Masterton W; Booth H; Ball L; Murdoch H; Falzon D; Pauly BM; Matheson C
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey.
    Radfar SR; De Jong CAJ; Farhoudian A; Ebrahimi M; Rafei P; Vahidi M; Yunesian M; Kouimtsidis C; Arunogiri S; Massah O; Deylamizadeh A; Brady KT; Busse A; ; Potenza MN; Ekhtiari H; Baldacchino AM
    Front Psychiatry; 2021; 12():639393. PubMed ID: 34025471
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary: Harm reduction, managed alcohol programs and doing the right thing.
    Gaetz S
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S195-S196. PubMed ID: 29737613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cups for COVID: rapid implementation of a harm reduction initiative to support populations experiencing homelessness during the COVID-19 pandemic.
    Steer KJD; Klassen DC; O'Gorman CM; Webster M; Mitchell M; Krichevsky L; Christiansen K; Benham JL; Schindler RS
    Can J Public Health; 2021 Feb; 112(1):29-35. PubMed ID: 33492656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspective.
    Narasimha VL; Butner JL; Hanafi E; Farokhnia M; Bhad R; Chalabianloo F; Kouimtsidis C; Baldacchino A; Arunogiri S
    BJPsych Int; 2022 Aug; 19(3):66-69. PubMed ID: 36287782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential for Managed Alcohol Programmes in Scotland during the COVID-19 Pandemic: A Qualitative Exploration of Key Areas for Implementation Using the Consolidated Framework for Implementation Research.
    Carver H; Parkes T; Masterton W; Booth H; Ball L; Murdoch H; Falzon D; Pauly BM
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and persons with substance use disorders: Inequities and mitigation strategies.
    Melamed OC; Hauck TS; Buckley L; Selby P; Mulsant BH
    Subst Abus; 2020; 41(3):286-291. PubMed ID: 32697172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs.
    Stowe MJ; Calvey T; Scheibein F; Arya S; Saad NA; Shirasaka T; Dannatt L; Ghosh A; Yee A; Ratta-Apha W; Vadivel R; Siste K; Shah B; Ramalho R; Narasimha VL; Delic M; Peyron E; Onoria JLG; Pant SB; Boujraf S; Grandinetti P; Morgan N
    J Addict Med; 2020 Dec; 14(6):e287-e289. PubMed ID: 33009167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and forced alcohol abstinence in India: The dilemmas around ethics and rights.
    Nadkarni A; Kapoor A; Pathare S
    Int J Law Psychiatry; 2020; 71():101579. PubMed ID: 32768113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harm reduction must be recognised an essential public health intervention during crises.
    Csák R; Shirley-Beavan S; McHenry AE; Daniels C; Burke-Shyne N
    Harm Reduct J; 2021 Dec; 18(1):128. PubMed ID: 34886861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.